Rxivist logo

Tumors subvert immune cell function to evade immune responses, yet the complex mechanisms driving immune evasion remain poorly understood. Here we show that tumors induce de novo steroidogenesis in T lymphocytes to evade anti-tumor immunity. Using a novel transgenic steroidogenesis-reporter mouse line we identify and characterize de novo steroidogenic immune cells. Genetic ablation of T cell steroidogenesis restricts primary tumor growth and metastatic dissemination in mouse models. Steroidogenic T cells dysregulate anti-tumor immunity, and inhibition of the steroidogenesis pathway was sufficient to restore anti-tumor immunity. This study demonstrates T cell de novo steroidogenesis as a mechanism of anti-tumor immunosuppression and a potential druggable target. ### Competing Interest Statement The authors have declared no competing interest.

Download data

  • Downloaded 913 times
  • Download rankings, all-time:
    • Site-wide: 13,115 out of 88,806
    • In immunology: 313 out of 2,553
  • Year to date:
    • Site-wide: 7,673 out of 88,806
  • Since beginning of last month:
    • Site-wide: 1,413 out of 88,806

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)